Scientific services
Innovative solutions for your business & research success. We are ready to partner with you to achieve extraordinary results.
We specialize in the technological challenges of high-resolution microscopy and high-content imaging in early-stage research for drug discovery.
With years of experience in industrial research and a global network, we can help you build successful collaborations and partnerships with leading companies. Together, we pave the way for your innovations and breakthrough discoveries.
We understand the complex landscape of large pharma companies and have a nuanced understanding of your unique challenges. Let us help you optimize efficient processes. Leverage our first-hand knowledge to drive successful research initiatives and project completions.
We enable your company to work successfully with large enterprises. Together, we develop customized, efficient workflows and optimize your processes. Let us work together to develop solutions that address your unique needs and challenges and pave the way to your competitive advantage.
We provide strategic guidance to help you align your business with industry standards. Together, we optimize your customized approach that accelerates growth and drives innovation. Potential hurdles become milestones, and you position your startup for a successful journey in the competitive landscape.
At CELLIMA, we believe that each customer has unique needs and deserves unique solutions. Our approach focuses on understanding your specific scientific challenges and goals.
We combine this insight with our extensive expertise to develop innovative, customized strategies. Our team works closely with you every step of the way to ensure that the solutions we deliver are not only state-of-the-art, but also perfectly aligned with your goals.
With CELLIMA, you can be confident that you’re getting a solution that’s as unique and forward-thinking as your project demands.
Innovation is at the heart of our work. CELLIMA strives to stay at the forefront of scientific progress so that you can efficiently utilize the latest research methods and technologies. We are problem solvers and innovators who understand future trends and challenges. This is how we develop relevant strategies for today that are prepared for the challenges of tomorrow.
CELLIMA enhances your scientific endeavors with our expertise in cutting-edge technologies, allowing you to not only meet industry standards, but to redefine them. Together with CELLIMA, you can transform your projects and develop new methods and technologies that reshape the scientific research landscape.
Every customer has unique challenges and goals. That is why CELLIMA places great emphasis on developing customized solutions that are specifically tailored to your needs. Our approach includes a thorough understanding of your project objectives so that we can tailor strategies and research to meet your needs. Our personalized service ensures efficient solutions that are perfectly aligned with your vision and requirements.
We are professional experts who are passionate about scientific progress. This fusion ensures that every project is approached with a commitment to excellence and goal achievement. With CELLIMA, you get more than just a consultant; you get a dedicated partner who will drive your success with expertise and genuine enthusiasm.
In order to better describe the current state and future prospects of High-Content Imaging, a market survey was conducted among researchers and organizations involved in early drug discovery worldwide.
Want to explore the groundbreaking intersection of cell biology and artificial intelligence in drug discovery? I was delighted to have the opportunity to discuss this topic with Niranj Chandrasekaran of the BROAD Institute on January 12, 2024. In this interview, we discussed the transformative role of cell painting and KI technologies in advancing drug discovery.
Join us for an exciting discussion on the use of specialized AI tools in early drug discovery. David Egan, CEO of Core Life Analytics and Philipp Kainz, CEO of KML Vision discuss the use of the latest developments in the field of advanced machine learning and deep learning.